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Summary
Two experiments were conducted to assess pregnancy outcomes after a 5-day Ovsynch-56 
Resynch (RES; gonadotropin-releasing hormone injection 5 days before [GnRH-1; d 0] and 
56 hours (GnRH-2) after PGF2α [PG] injections on day 5 and 6, timed artificial insemination 
[TAI] on day 8) with and without a progesterone-releasing intravaginal controlled internal 
drug release (CIDR) 5-day insert. In Exp. 1, nonpregnant cows were enrolled on day 34 post-
AI: day 34 RES-CON (n = 528) or day 34 RES-CIDR (n = 503). Blood was collected for 
progesterone assay. Pregnancy per AI (P/AI) was diagnosed by uterine palpation per rectum at 
34 and 62 days post-TAI. Only 76% of 1,031 cows had high progesterone (≥1 ng/mL) on day 
34 at the nonpregnant diagnosis. No differences in P/AI were detected between treatments. 
The day-34 RES-CIDR cows with low (<1 ng/mL) progesterone, however, had greater  
(P = 0.036) P/AI than day-34 RES-CON cows (37.7 vs. 29.4%), whereas day-34 RES-CIDR 
cows with high progesterone had lesser P/AI than day-34 RES-CON (27.4 vs. 34.3%). In Exp. 
2, cows were enrolled on day 31 post-AI after a nonpregnant diagnosis: (1) day 31 PG-3-G  
(n = 102): Pre-PG on day 31, Pre-GnRH on day 34, and RES on day 41 (n = 102); (2) day 41 
RES-CON (n = 108) as Exp. 1, but on day 41; and (3) day 41 RES-CIDR (n = 101) as Exp. 2, 
but on day 41. Blood was collected for progesterone assay and ovarian structures were mapped 
by ultrasonography on days 31, 34, 41, 46, and 48. Pregnancy was diagnosed by ultrasonography 
on days 31 and 59 post-TAI. The proportion of cows with high progesterone on day 31 was 
70.6%. More (P < 0.001) cows ovulated after Pre-GnRH on day 31 PG-3-G (60.4%) than for 
day 41 RES-CON (12.5%) or day 41 RES-CIDR (17.1%). More (P < 0.001) PG-3-G cows had 
luteolysis after Pre-PG on day 31 than other treatments (73.7 vs. < 11%). The proportion of 
cows with high progesterone on day 41 at GnRH-1 tended (P = 0.10) to be greater for PG-3-G 
(75.6%) than for other treatments (65 to 70%). The P/AI was greater in cows starting RES 
on day 41 when progesterone was low (44%) than when it was high (33%), but no treatment 
differences were detected 31 days after TAI (PG-3-G = 33.3%; d 41 RES-CON = 38.9%; d 41 
RES-CIDR = 35.6%). We concluded that improved P/AI for cows initiating the 5-day RES 
on day 34 without a corpus luteum is progesterone-dependent because addition of the CIDR 
insert to the RES treatment improved P/AI in cows with low progesterone (Exp. 1). Although 
day-31 PG-3-G increased luteolysis and produced greater ovulation rates before the onset of 
RES, no increase in P/AI was detected compared with RES started on day 41 with or without a 
CIDR insert.
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Introduction
Lactating dairy cows generally have poorer pregnancy outcomes at second and subsequent 
services when timed artificial insemination (TAI) programs are applied. Currently, many 
well-managed dairies are achieving TAI pregnancies in the 40% range at first service after calv-
ing. Pregnancy outcomes for TAI repeat services are in the 30 to 35% range for the most part. 
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Poorer pregnancy outcomes of repeat or Resynch (RES) inseminations seem to be associated 
with poorer ovulatory responses to gonadotropin-releasing hormone (GnRH) and failure of the 
corpus luteum to regress in response to PGF2α (PG). Studies in which open cows are pretreated 
with GnRH or human chorionic gonadotropin (hCG) 7 days before RES have improved 
pregnancy outcomes, but they also extend the inter-insemination interval for individual cows 
because of the delay between open diagnosis and re-insemination. Injecting PG 7 or 11 days 
before RES also delays reinsemination, but when coupled with detection of estrus, more cows 
are reinseminated before the follow-up RES is applied to those cows not inseminated.
Our objective was to determine the value of applying progesterone in the form of a CIDR insert 
to cows diagnosed open at day 34 after last insemination (Exp. 1). A second experiment was 
performed with the same objective. The RES program with or without the CIDR insert, howev-
er, was applied on day 41, and a third treatment included a presynchronization (PG + GnRH) 
treatment before RES. In both experiments, a 5-day RES-Ovsynch protocol was used.
Experimental Procedures
Lactating dairy cows from two herds in northeast Kansas were enrolled in the study. All cows 
were milked three times daily and fed diets consisting of alfalfa hay, corn silage, soybean meal, 
whole cottonseed, corn or milo grain, corn gluten feed, vitamins, and minerals.
The herd enrolled in Exp. 1 comprised cows (n = 1,031) diagnosed open 34 days (range of 34 
to 40 days, with the majority of cows on day 34) post-AI by uterine palpation per rectum by 
a single veterinarian from September 2010 through October 2012. Non-pregnant cows were 
assigned randomly to a 5-d Ovsynch-56 Resynch (RES; GnRH injection 5 days before [GnRH-
1; day 0] and 56 hours (GnRH-2) after PGF2α [PG] injections on days 5 and 6, TAI on day 8) 
with (day-34 RES-CON, n = 528) or without a progesterone-releasing intravaginal controlled 
internal drug release (CIDR) 5-day insert (day-34 RES-CIDR, n = 503, Figure 1).
The herd enrolled in Exp. 2 comprised cows (n = 209) diagnosed open 31 days (range of 30 
to 36 days, with the majority of cows on day 31) post-AI by transrectal ultrasonography from 
November 2010 through October 2012. Non-pregnant cows were assigned randomly to either 
day-31 PG-3-G (Pre-PG on day 31, Pre-GnRH on day 34, and RES on day 41; n = 102), day-
41 RES-CON (same as in Exp. 1, but on day 41; n = 108) or day-41 RES-CIDR (as Exp. 2 but 
on day 41, n =101, Figure 2). Ovarian structures were recorded and mapped by ultrasonogra-
phy on days 31, 41, 46, and 48 to determine the incidence of luteolysis, ovulation, and double 
ovulation in all cows. Cows returning to estrus before TAI were inseminated and designated as 
early bred (EB).
Pregnancy per AI (P/AI) was diagnosed at 34 days and confirmed at 62 days post-TAI by uter-
ine palpation per rectum by a single veterinarian (Exp. 1) or at 31 days and confirmed 59 days 
post-TAI by ultrasonography (Exp. 2).
Blood was sampled from all cows by puncture of the coccygeal vein or artery into evacuated 
tubes at nonpregnant diagnosis. Blood samples were collected to determine progesterone con-
centrations at either day 34 (Exp. 1) or at days 31, 34, 46, and 48 (Exp. 2). Samples were im-
mediately cooled and stored at 5°C for 16 hours. Blood tubes were centrifuged at 1,000 x g for 
15 minutes in a refrigerated centrifuge at 5°C for serum separation and harvest. Serum samples 
were frozen and stored at -20°C until assayed for progesterone by radioimmunoassay.
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Results and Discussion
Experiment 1
Only 76% of 1,031 cows had high (≥1 ng/mL) progesterone concentrations at day-34 non-
pregnant diagnosis. Cows with low (<1 ng/mL) progesterone concentrations at GnRH-1 and 
assigned to the day-34 RES-CIDR treatment had greater (P = 0.028) P/AI than day-34 RES-
CON cows (39.1 vs. 31.3%; Figure 3). In contrast, day-34 RES-CIDR–treated cows with high 
progesterone concentrations had reduced P/AI compared with cows that received the day-34 
RES-CON treatment (27.4 vs. 34.3%).
It seems clear from this experiment that no benefit to pregnancy outcome is accrued from using 
CIDR in a Resynch application for cows with elevated progesterone (functional corpus luteum; 
76% of cows treated) at the onset of a 5-day Resynch program for cows that are between days 
34 and 40 since last insemination. Increased P/AI was observed in cows treated with the CIDR 
insert only when they had low progesterone (no corpus luteum; 24% of cows treated) at the 
onset of RES.
Experiment 2
The proportion of cows with high progesterone on day 31 was 70.6%. More (P < 0.001) cows 
ovulated after Pre-GnRH of day-31 PG-3-G than for day-41 RES-CON or day-41 RES-CIDR 
(Table 1). More (P < 0.001) PG-3-G cows had luteolysis after Pre-PG on day 31 than other 
treatments (Table 1). The proportion of cows with high progesterone on day 41 at GnRH-1 
tended (P = 0.10) to be greater for PG-3-G than for other treatments (Table 1). The P/AI was 
greater in cows starting RES on day 41 when progesterone was low (44%) than when it was 
high (33%), but no overall treatment differences in P/AI were detected 32 days after TAI  
(PG-3-G = 33.3%; day-41 RES-CON = 38.9%; day-41 RES-CIDR = 35.6%; Figure 4).
Some have reported improved P/AI in RES cows in which the RES protocol was delayed after 
open diagnosis and cows were pretreated with PG before initiating the RES protocol. Most of 
the advantage of using PG is accrued by inseminating those cows that are detected in estrus and 
enrolling only those not yet inseminated in the follow-up RES protocol. Therefore, although no 
P/AI advantage occurred after pretreating open cows with PG, the major benefit accrued when 
detection of estrus was included as part of the program before applying the RES protocol to 
cows not inseminated.
We concluded that improved P/AI occurred only when applying the CIDR insert to cows with 
low progesterone when initiating the 5-day RES on d 34 (Exp. 1). Although d 31 PG-3-G in-
creased rates of luteolysis and ovulation before RES, no increase in P/AI was detected compared 
with the 5-day RES started on d 41 with or without a CIDR insert (Exp. 2).
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Table 1. Ovarian characteristics during Experiment 2 treatment protocols
Treatment
Item
Day-31  
PG-3-G
Day-41  
RES-CON
Day-41  
RES-CIDR P-values
Pre-PG/GnRH
Progesterone ≥ 1 ng/mL, % 74.8 69.3 67.6 0.42
Luteolysis1, % 73.8a 10.4b 8.7b 0.001
Ovulation after Pre-GnRH2,% 60.4a 12.5b 17.1b 0.001
GnRH-1
Progesterone ≥ 1 ng/mL, % 76.6a 65.5b 70.2a,b 0.05
CL present, % 78.5 73.4 67.0 0.13
Ovulation after GnRH2, % 42.1a 36.3a,b 28.3b 0.05
Double ovulation after GnRH3,% 8.4 4.4 5.7 0.46
GnRH-2
Luteolysis4, % 96.6 93.5 95.7 0.63
Ovulation after GnRH2,% 88.6 85.0 84.9 0.67
Double ovulation after GnRH3,% 19.1 28.3 24.5 0.18
a,b Proportions within each row with different superscripts differ (P < 0.05).
1 Luteolysis was determined by changes in progesterone concentration between Pre-PG (≥ 1 ng/mL) and Pre-GnRH injec-
tions 72 hours later (< 1 ng/mL).
2 Ovulation of one follicle after GnRH administration.
3 Ovulation of more than one follicle after GnRH administration. 
4 Luteolysis was determined by changes in progesterone concentration between PG-2 (≥ 1 ng/mL) and GnRH-2 injections 
72 hours later (< 1 ng/mL). 
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  Figure 1. Experimental design for Experiment 1. PG = PGF2a, GnRH = gonadotropin-releasing 
hormone, TAI = timed artificial insemination, CIDR = controlled internal drug release insert 
(progesterone impregnated), P4 = progesterone, PD = pregnancy diagnosis.
	  Figure 2. Experimental design for Experiment 2. PG = PGF2a, GnRH = gonadotropin-releasing 
hormone, TAI = timed artificial insemination, CIDR = controlled internal drug release insert 
(progesterone impregnated), P4 = progesterone, PD = pregnancy diagnosis, US = ovarian ultra-
sound examination.
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Figure 3. Pregnancy per timed AI determined 34 days post-insemination (Exp. 1) based on  
treatment and progesterone concentration at the onset of treatment.
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Figure 4. Pregnancy per timed AI at 32 days post-insemination for Experiment 2.
